Merck Receives Approval of ZEPATIER™

Related Videos
Video Discription: Merck Receives Approval of ZEPATIER™ (elbasvir/grazoprevir) in Canada for the Treatment of Chronic Hepatitis C for Patients with Genotype 1, 3, or 4 Infection Following Priority Review - http://dld.bz/em2kD

--

Video Just Watched

Dailymotion.com

Youtube.com